 |
|
|
| |
Antiviral Activity of Tenofovir Alafenamide (TAF) against Major NRTI-Resistant Viruses:
Improvement over TDF/TFV is Driven by Higher TFV-DP Loading in Target cells
|
| |
| |
Reported by Jules Levin
International Workshop on HIV & Hepatitis
Virus Drug Resistance and Curative Strategies
June 4-8, 2013
Toronto, Canada
N Margot, Y Liu, D Babusis, MD Miller, C Callebaut
Gilead Sciences Inc, Foster City, CA, United States
|
| |
|
|
|
|
|
